FAQ/Help |
Calendar |
Search |
Today's Posts |
04-30-2019, 07:07 AM | #16 | ||
|
|||
Member
|
"The fourth subject of the third cohort, who was the twelfth and final subject of the phase 1 clinical study, was successfully transplanted with the highest dose of ISC-hpNSC® stem cells."
"Interim results of this study will be presented at the upcoming 2019 American Academy of Neurology 71st Annual Meeting in Philadelphia, PA on May 5th, 2019." International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial Other OTC:ISCO |
||
Reply With Quote |
"Thanks for this!" says: | RooJr (04-30-2019), soccertese (04-30-2019) |
|
|
Similar Threads | ||||
Thread | Forum | |||
Fetal cells injected into a man's brain to cure his Parkinson's | Parkinson's Disease | |||
Review Interventions that Improve Body and Brain Bioenergetics for Parkinson’s Diseas | Parkinson's Disease | |||
Healing Parkinson's patients with their own stem cells - patient funded | Parkinson's Disease | |||
Whom to believe? Study: Virus injected into brain eases Parkinson’s in Japan | Parkinson's Disease |